Benefit of adjuvant chemotherapy on recurrence free survival per consensus molecular subtype in stage III colon cancer
Ontology highlight
ABSTRACT: In this study, we evaluated the added value of CMS in predicting both prognosis and benefit of adjuvant chemotherapy in stage III CC patients.
ORGANISM(S): Homo sapiens
PROVIDER: GSE250057 | GEO | 2024/07/10
REPOSITORIES: GEO
ACCESS DATA